Hybrigenics SA (ALHYG)
Euronext
Closed
Oct 8, 2026
Day's Range
0.013052 wk Range
0.00500Overview - ALHYG - Hybrigenics SA
Key Statistics
Valuation
P/E (Trailing)
‪-0.28‬
P/E (Forward)
‪-0.06‬
Price / Sales (TTM)
‪14.17‬
Profitability
Profit Margin
‪-38.13%‬
Operating Margin
‪-3,485.50%‬
Return on Assets
‪-1,828.05%‬
Return on Equity
‪402.19%‬
Ownership
Shares Outstanding
383.15M
Market Cap - ALHYG - Hybrigenics SA
Peers - ALHYG - Hybrigenics SA
Peer Comparison
Compared with companies in Biotechnology listed on Euronext.
- ALHYGEuronextHybrigenics SA5.44MMarket Cap+45.07%52-week change-0.29P/E (Trailing)‪-38.13%‬Profit Margin
- ARGXEuronextargenx SE52.87BMarket Cap+27.69%52-week change36.64P/E (Trailing)‪32.26%‬Profit Margin
- AGNEuronextAegon Ltd.11.21BMarket Cap+10.13%52-week change11.66P/E (Trailing)‪8.62%‬Profit Margin
- ABVXEuronextAbivax SA7.14BMarket Cap+13.43%52-week change-16.96P/E (Trailing)‪0.00%‬Profit Margin
- ALVIOEuronextValerio Tx Corp.279.69MMarket Cap+89.64%52-week change—P/E (Trailing)‪-190.36%‬Profit Margin
- AVTXEuronextAvantium N.V.126.03MMarket Cap-46.80%52-week change-2.94P/E (Trailing)‪-154.30%‬Profit Margin
- ALCLSEuronextCellectis S.A.125.69MMarket Cap-81.49%52-week change-1.86P/E (Trailing)‪-102.33%‬Profit Margin
Profile Summary - ALHYG - Hybrigenics SA
About
Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
